THEUER CHARLES 4
4 · 4D Molecular Therapeutics, Inc. · Filed Dec 16, 2025
Insider Transaction Report
Form 4
THEUER CHARLES
Director
Transactions
- Exercise/Conversion
Common Stock
2025-12-12$1.14/sh+9,333$10,640→ 41,684 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-12-12−9,333→ 0 totalExercise: $1.14Exp: 2026-03-09→ Common Stock (9,333 underlying)
Footnotes (1)
- [F1]Fully vested.